NASDAQ NMS - GLOBAL MARKET · OKUR
-0.24% · -$0.0100 · Vol 85.0K
Market closed · last close 4:00 PM ET · price as of 16:01:47 ET
Onkure Therapeutics Inc

Onkure Therapeutics Inc

Biotechnology
$4.14
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
OKUR
Onkure Therapeutics Inc
Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

58/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is OKUR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading OKUR catalysts
About Onkure Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
45
Country
US

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.24
Day high
$4.26
Day low
$4.01
Previous close
$4.15
52W high
$5.27
-21.44% from high
52W low
$2.00
65% of range
Market cap
$168.1M
EPS
$-3.6500
Beta
0.79
Shares out
40.5M
Volume
85K
0.32× rel vol
Avg volume
265.5K
VWAP
$4.11
Price history computed in-house
1W
+8.38%
1M
-7.17%
3M
+5.88%
1Y
+102.94%
YTD
+42.76%
SMA 50 $4.24 · below
SMA 200 $3.59 · above
52W position 65%

OKUR overview

Veridion Score
58
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around OKUR.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading OKUR Form 4 filings
Public disclosures

Congress activity in OKUR

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for OKUR in the cached public ledger.

Federal contracts

OKUR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OKUR in this window.
Lobbying spend

OKUR lobbying filings, year to date.

Registered lobbying filings matched to Onkure Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for OKUR in this window.
Loading news for OKUR
Analyst ratings
Sovereign unlock shows live analyst consensus for OKUR.
Options
Sovereign unlock shows live options positioning for OKUR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.